Overview of HPV associated Cervical carcinoma

Cervical carcinoma is a cancer arising from the cervix.It is due to the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Early on, typically no symptoms are seen.Later symptoms may include abnormal vaginal bleeding, pelvic pain or pain during sexual intercourse.While bleeding after sex may not be serious, it may also indicate the presence of cervical cancer.


ID Literature Title Group
1 29364907 HPV integration hijacks and multimerizes a cellular enhancer to generate a viral-cellular super-enhancer that drives high viral oncogene expression.
VIS-cistrome
2 24201445 Genome-wide analysis of HPV integration in human cancers reveals recurrent, focal genomic instability.
VIS-cistrome
3 26660085 Chromosomal copy number alterations and HPV integration in cervical precancer and invasive cancer.
VIS-cistrome
4 23740984 Landscape of DNA virus associations across human malignant cancers: analysis of 3,775 cases using RNA-Seq.
VIS-cistrome
5 23824673 Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas.
VIS-cistrome
6 18922896 Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions.
VIS-cistrome
7 30679491 TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration.
VIS-cistrome
8 24418928 Simultaneous characterization of somatic events and HPV-18 integration in a metastatic cervical carcinoma patient using DNA and RNA sequencing.
VIS-cistrome
9 26735580 Comprehensive mapping of the human papillomavirus (HPV) DNA integration sites in cervical carcinomas by HPV capture technology.
VIS-cistrome
10 27759101 Genome-wide profiling of the human papillomavirus DNA integration in cervical intraepithelial neoplasia and normal cervical epithelium by HPV capture technology.
VIS-cistrome
11 25485619 A comprehensive transcriptional portrait of human cancer cell lines.
VIS-cistrome
12 32714374 Accurate Detection of HPV Integration Sites in Cervical Cancer Samples Using the Nanopore MinION Sequencer Without Error Correction.
VIS-cistrome
13 33191407 Human papilloma virus (HPV) integration signature in Cervical Cancer: identification of MACROD2 gene as HPV hot spot integration site.
VIS-cistrome
14 30567904 Comprehensive genomic variation profiling of cervical intraepithelial neoplasia and cervical cancer identifies potential targets for cervical cancer early warning.
VIS-cistrome
15 32025001 The landscape of viral associations in human cancers.
VIS-cistrome
16 29487700 Increased high mobility group A 2 expression promotes transition of cervical intraepithelial neoplasm into cervical cancer.
VIS-cistrome
17 31014281 HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports.
VIS-cistrome
18 32631904 The D2 and D3 Sublineages of Human Papilloma Virus 16-Positive Cervical Cancer in Guatemala Differ in Integration Rate and Age of Diagnosis.
VIS-cistrome
19 30728408 Genome-wide profiling of human papillomavirus DNA integration in liquid-based cytology specimens from a Gabonese female population using HPV capture technology.
VIS-cistrome
20 30552977 Characterization of HPV integration, viral gene expression and E6E7 alternative transcripts by RNA-Seq: A descriptive study in invasive cervical cancer.
VIS-cistrome
21 33023834 HPV-CCDC106 integration alters local chromosome architecture and hijacks an enhancer by three-dimensional genome structure remodeling in cervical cancer.
VIS-cistrome
22 10389753 Uniform distribution of HPV 16 E6 and E7 variants in patients with normal histology, cervical intra-epithelial neoplasia and cervical cancer.
Mutation
23 10567656 Human papillomavirus type 16 E6 variants in cervical carcinoma: relationship to host genetic factors and clinical parameters.
Mutation
24 10783118 Absence of antibody against human papillomavirus type 16 E6 and E7 in patients with cervical cancer is independent of sequence variations.
Mutation
25 10880765 Enhanced oncogenicity of human papillomavirus type 16 (HPV16) variants in Japanese population.
Mutation
26 10917543 Uneven distribution of HPV 16 E6 prototype and variant (L83V) oncoprotein in cervical neoplastic lesions.
Mutation
27 11745467 Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes.
Mutation
28 11870518 Variants of the long control region and the E6 oncogene in European human papillomavirus type 16 isolates: implications for cervical disease.
Mutation
29 12189229 Association of human papillomavirus type 58 variant with the risk of cervical cancer.
Mutation
30 12195358 Human papillomavirus type 16 intratypic variant infection and risk for cervical neoplasia in southern China.
Mutation
31 12691704 Association between human papillomavirus 16 E6 variants and human leukocyte antigen class I polymorphism in cervical cancer of Swedish women.
Mutation
32 12820481 Co-mutation of HPV16 E6 and E7 genes in Thai squamous cervical carcinomas.
Mutation
33 12918070 Human papillomavirus type 16 E6 variants and HLA class II alleles among Japanese women with cervical cancer.
Mutation
34 1321216 Geographical dependence of sequence variation in the E7 gene of human papillomavirus type 16.
Mutation
35 15297193 Human papillomavirus type 16 E6, E7, and L1 variants in cervical cancer in Indonesia, Suriname, and The Netherlands.
Mutation
36 15363193 [Analysis of human papillomavirus 16 E6 oncogene mutation in Xinjiang Uygur women with cervical carcinoma].
Mutation
37 15491758 E2 sequence variations of HPV 16 among patients with cervical neoplasia seen in the Indian subcontinent.
Mutation
38 15572004 The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
Mutation
39 15670304 Polymorphism in the E6 gene of human papillomavirus type 16 in the cervical tissues of Korean women.
Mutation
40 15721413 Human papillomavirus type 16 E2 and E6/E7 variants.
Mutation
41 15929080 Interaction of host and viral risk factors for development of cervical carcinoma in situ.
Mutation
42 16012730 Sequence variation and the transcriptional activity of the upstream regulatory region in human papillomavirus 16 E7 variants in cervical cancer of Korean women.
Mutation
43 16099904 Differential splicing of E6 within human papillomavirus type 18 variants and functional consequences.
Mutation
44 16333213 [Investigation of human papillomavirus, its types and variants].
Mutation
45 16603519 Analysis of mutations in the E6/E7 oncogenes and L1 gene of human papillomavirus 16 cervical cancer isolates from China.
Mutation
46 18199779 Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Mutation
47 18512138 A non-radioactive PCR-SSCP analysis allows to distinguish between HPV 16 European and Asian-American variants in squamous cell carcinomas of the uterine cervix in Colombia.
Mutation
48 19256739 Distribution of HPV-16 intratypic variants among women with cervical intraepithelial neoplasia and invasive cervical cancer in Mongolia.
Mutation
49 19358280 Molecular variants of HPV-16 associated with cervical cancer in Indian population.
Mutation
50 19699050 Human papillomavirus type 16 E6 gene variations in Chinese population.
Mutation
51 20104743 [Gene characterization of E6 and E7 gene of human papillomavirus of 15 cervical cancer in Beijing].
Mutation
52 20423887 [Human papillomavirus type 16 variant analysis of upstream regulatory region and E6, E7 oncogene from cervical cancer patients in Beijing].
Mutation
53 20870281 Distribution of human papillomavirus 58 and 52 E6/E7 variants in cervical neoplasia in Chinese women.
Mutation
54 21051983 Distribution of human papillomavirus 16 E6/E7 variants in cervical cancer and intraepithelial neoplasia in Chinese women.
Mutation
55 21436703 Genetic diversity of HPV-16 E6, E7, and L1 genes in women with cervical lesions in Liaoning Province, China.
Mutation
56 21593270 Human papillomavirus type 16 variant analysis of E6, E7, and L1 [corrected] genes and long control region in [corrected] cervical carcinomas in patients in northeast China.
Mutation
57 22131113 Prevalence of HPV 16 genomic variant carrying a 63 bp duplicated sequence within the E1 gene in Slovenian women.
Mutation
58 22524831 Whole genome analysis of human papillomavirus type 16 multiple infection in cervical cancer patients.
Mutation
59 22558401 Human papillomavirus (HPV) 16 E6 variants in tonsillar cancer in comparison to those in cervical cancer in Stockholm, Sweden.
Mutation
60 22574185 Whole genome sequencing and evolutionary analysis of human papillomavirus type 16 in central China.
Mutation
61 22622951 Variant lineages of human papillomavirus type 18 in Northeast China populations characterized by sequence analysis of E6, E7, and L1 regions.
Mutation
62 22659102 Variations of human papillomavirus type 58 E6, E7, L1 genes and long control region in strains from women with cervical lesions in Liaoning province, China.
Mutation
63 23136059 Geographical distribution and oncogenic risk association of human papillomavirus type 58 E6 and E7 sequence variations.
Mutation
64 23203106 Genomic polymorphism of human papillomavirus type 52 in women from Northeast China.
Mutation
65 23451059 Sequence variation analysis of HPV-18 isolates in southwest China.
Mutation
66 23762404 Differential expression of HPV16 L2 gene in cervical cancers harboring episomal HPV16 genomes: influence of synonymous and non-coding region variations.
Mutation
67 23881083 Nucleotide polymorphisms of the human papillomavirus 16 E1 gene.
Mutation
68 23946477 Molecular and evolutionary analysis of HPV16 E6 and E7 genes in Greek women.
Mutation
69 23953248 Analysis of mutations in the E6 oncogene of human papillomavirus 16 in cervical cancer isolates from Moroccan women.
Mutation
70 24099556 Genetic variations of E6 and long control region of human papillomavirus type 16 from patients with cervical lesion in Liaoning, China.
Mutation
71 24150786 Functional effects of sequence variations in the E6 and E2 genes of human papillomavirus 16 European and Asian variants.
Mutation
72 24236186 Genetic variation of human papillomavirus type 16 in individual clinical specimens revealed by deep sequencing.
Mutation
73 24610458 HPV16 E6 variants: frequency, association with HPV types and in silico analysis of the identified novel variants.
Mutation
74 25111286 Prevalence of HPV and variation of HPV 16/HPV 18 E6/E7 genes in cervical cancer in women in South West China.
Mutation
75 25143263 Molecular variants of human papilloma virus 16 E2, E4, E5, E6 and E7 genes associated with cervical neoplasia in Romanian patients.
Mutation
76 25735347 Mutation detection of E6 and LCR genes from HPV 16 associated with carcinogenesis.
Mutation
77 25889023 Association of human papillomavirus 16 E6 variants with cervical carcinoma and precursor lesions in women from Southern Mexico.
Mutation
78 25991921 Genetic variability in E6 and E7 oncogenes of human papillomavirus Type 16 from Congolese cervical cancer isolates.
Mutation
79 26192265 Distribution of human papilloma virus type 16 E6/E7 gene mutation in cervical precancer or cancer: A case control study in Guizhou Province, China.
Mutation
80 27610192 Molecular analysis of human Papillomavirus detected among women positive for cervical lesions by visual inspection with acetic acid/Lugol's iodine (VIA/VILI) in Libreville, Gabon.
Mutation
81 27801430 HPV16 E6 polymorphism and physical state of viral genome in relation to the risk of cervical cancer in women from the south of Poland.
Mutation
82 27977741 Analysis of Sequence Variation and Risk Association of Human Papillomavirus 52 Variants Circulating in Korea.
Mutation
83 28036379 Different Association of Human Papillomavirus 16 Variants with Early and Late Presentation of Cervical Cancer.
Mutation
84 28141822 E6 and E7 Gene Polymorphisms in Human Papillomavirus Types-58 and 33 Identified in Southwest China.
Mutation
85 28270859 Genetic variability in E6, E7 and L1 genes of Human Papillomavirus 62 and its prevalence in Mexico.
Mutation
86 28325903 Whole-Genome Analysis of Human Papillomavirus Types 16, 18, and 58 Isolated from Cervical Precancer and Cancer Samples in Chinese Women.
Mutation
87 28441787 Codon Usage Optimization and Construction of Plasmid Encoding Iranian Human Papillomavirus Type 16 E7 Oncogene for Lactococcus Lactis Subsp. Cremoris MG1363
Mutation
88 28591310 Human papillomavirus type distribution and HPV16 intratype diversity in southern Brazil in women with and without cervical lesions.
Mutation
89 28767682 Genetic variability and functional implication of the long control region in HPV-16 variants in Southwest China.
Mutation
90 28819444 Association of HLA-DRB1, HLA-DQB1 Polymorphisms with HPV 16 E6 Variants among Young Cervical Cancer Patients in China.
Mutation
91 28959092 Naturally occurring capsid protein variants L1 of human papillomavirus genotype 16 in Morocco.
Mutation
92 28988982 Phylogenetic analysis of Human papillomavirus 16 variants isolated from Indian Breast cancer patients showed difference in genetic diversity with that of cervical cancer isolates.
Mutation
93 29783960 Performance of OncoE6 cervical test with collection methods enabling self-sampling.
Mutation
94 29945151 Genetic Variability in E6 and E7 Oncogenes from Human Papillomavirus Type 58 in Mexican Women.
Mutation
95 30008422 The association of human papillomavirus type 16 E2 variations with cervical cancer in a Han Chinese population.
Mutation
96 30081093 HPV16 E2 variants correlated with radiotherapy treatment and biological significance in cervical cell carcinoma.
Mutation
97 30161236 Differences in the viral genome between HPV-positive cervical and oropharyngeal cancer.
Mutation
98 30583341 Phylogeny and Classification of Human Papillomavirus (HPV)16 and HPV18 Variants Based on E6 and L1 genes in Tunisian Women with Cervical Lesions
Mutation
99 30930693 Genetic variations in E6, E7 and the long control region of human papillomavirus type 16 among patients with cervical lesions in Xinjiang, China.
Mutation
100 30981880 Human papillomavirus type 16 E6 and E7 gene variations associated with cervical cancer in a Han Chinese population.
Mutation
101 30995759 Whole-Genome Analysis of Human Papillomavirus Type 16 Prevalent in Japanese Women with or without Cervical Lesions.
Mutation
102 31289133 The HPV16 Genome Is Stable in Women Who Progress to In Situ or Invasive Cervical Cancer: A Prospective Population-Based Study.
Mutation
103 31341418 Human Papillomavirus Type 16 E1 Mutations Associated with Cervical Cancer in a Han Chinese Population.
Mutation
104 31493439 Distribution of HPV 16 E6 gene variants in screening women and its associations with cervical lesions progression.
Mutation
105 31552532 Mutational landscape and intra-host diversity of human papillomavirus type 16 long control region and E6 variants in cervical samples.
Mutation
106 32308546 Association of Human Papillomavirus Type 16 Long Control Region Variations with Cervical Cancer in a Han Chinese Population.
Mutation
107 32448303 Fifteen new nucleotide substitutions in variants of human papillomavirus 18 in Korea : Korean HPV18 variants and clinical manifestation.
Mutation
108 32677948 Genetic variability, phylogeny and functional implication of the long control region in human papillomavirus type 16, 18 and 58 in Chengdu, China.
Mutation
109 32986347 Phylogeny and In Silico Structure Analysis of Major Capsid Protein (L1) Human Papillomavirus 45 from Indonesian Isolates.
Mutation
110 33324377 High Levels of Within-Host Variations of Human Papillomavirus 16 E1/E2 Genes in Invasive Cervical Cancer.
Mutation
111 33324386 Human Papillomavirus Infections in Cervical Samples From HIV-Positive Women: Evaluation of the Presence of the Nonavalent HPV Genotypes and Genetic Diversity.
Mutation
112 9485042 Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype.
Mutation
113 33909391 Sequence variation analysis of the E1 and E2 genes of human papillomavirus type 16 in cervical lesions in women from the south of Poland.
Mutation
Contents
Description
Group Note
  • Mutation Tag: literature about this virus mutation and click the eye icon to see detail mutation information in literature
  • VIS-cistrome Tag: literature associated this virus integration and click the eye icon to see detail information of 3 cistrome factors (histone modification, transcription factor binding site and chromatin accessibility)